本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Fennec Pharmaceuticals Inc.

8.00
-0.2500-3.03%
盤後8.000.00000.00%16:10 EST
成交量:6.38萬
成交額:51.33萬
市值:2.23億
市盈率:-17.95
高:8.25
開:8.25
低:7.94
收:8.25
52周最高:9.92
52周最低:3.96
股本:2,783.17萬
流通股本:1,461.70萬
量比:0.81
換手率:0.44%
股息:- -
股息率:- -
每股收益(TTM):-0.4458
每股收益(LYR):-0.0160
淨資產收益率:-1005.59%
總資產收益率:-11.20%
市淨率:-29.83
市盈率(LYR):-500.81

資料載入中...

2025/11/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/04

重要事件披露

Form 8-K - Current report
2025/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/10

重要事件披露

Form 8-K - Current report
2025/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/07

重要事件披露

Form 8-K - Current report
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities